Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia.

Orvain, Corentin; Rodríguez-Arbolí, Eduardo; Othus, Megan; Sandmaier, Brenda M; Deeg, H Joachim; Appelbaum, Frederick R; Walter, Roland B

Orvain, Corentin; Rodríguez-Arbolí, Eduardo; Othus, Megan; Sandmaier, Brenda M; Deeg, H Joachim; Appelbaum, Frederick R; Walter, Roland B.

Afiliação

Orvain C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Rodríguez-Arbolí E; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA 98195, USA.
Othus M; Maladies du Sang, CHU d'Angers, 49000 Angers, France.
Sandmaier BM; Fédération Hospitalo-Universitaire Grand-Ouest Acute Leukemia, FHU-GOAL, 49033 Angers, France.
Deeg HJ; Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes Université, 49000 Angers, France.
Appelbaum FR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Walter RB; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, 41013 Seville, Spain.

Cancers (Basel) ; 15(2)2023 Jan 05.

Article em En | MEDLINE | ID: mdl-36672303

Palavras-chave

acute myeloid leukemia (AML); allogeneic hematopoietic cell transplantation (HCT); antecedent hematologic disease (AHD); prognostication; therapy-related

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google